Latest Headlines

  1. InterSystems And Rhodes Group Streamline Mobile Specimen Collection And Labeling Procedures
    7/22/2019

    InterSystems, a global leader in health information technology, and Rhodes Group, a specialized laboratory software company, announced the launch of eMyLabCollect, a cloud-based application built to streamline specimen collecting, tracking, and labeling and to automate laboratory receiving and processing procedures

  2. LabCorp Expands Consumer-Initiated Test Offering
    7/22/2019

    LabCorp, a leading global life sciences company, recently announced a significant expansion to its Pixel by LabCorp platform

  3. UTEP Professor’s Prostate Cancer Detection Test Could Limit Blood Tests, Unnecessary Biopsies
    7/22/2019

    Wen-Yee Lee, Ph.D., associate professor of chemistry at The University of Texas at El Paso, has developed an affordable early screening test for prostate cancer. The test uses a small urine sample and, in the future, could be developed as a kit similar to the home pregnancy test

  4. Ultra-Clean Deep Well Plate Range Extended
    7/22/2019

    Porvair Sciences has extended its sample storage and collection range with the introduction of 5 new deep well microplates

  5. Biocept Announces Laboratory Services Provider Agreement With BeaconLBS®
    7/22/2019

    Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it has entered into a Laboratory Services Provider Agreement with Beacon Laboratory Benefit Solutions, Inc. (BeaconLBS®), a nationally recognized premier provider of laboratory benefit management technology solutions to health and managed care companies in the United States. BeaconLBS administers laboratory benefit management programs for health plans to improve test ordering efficiency, test appropriateness, affordability, and quality of care for health plan members

  6. Study Investigates The Ability Of Continuous Noninvasive Hemoglobin Monitoring With Masimo SpHb To Reflect Acute Hemodilution During Incremental Fluid Administration
    7/22/2019

    Masimo announced recently that in a study recently published in Anesthesia & Analgesia, researchers evaluated the ability of noninvasive and continuous hemoglobin monitoring with Masimo SpHb to detect the development of acute hemodilution after graded fluid administration, by comparing it to invasively measured laboratory hemoglobin (BHb), on patients undergoing major surgery

  7. Titan Medical Completes Preclinical Good Laboratory Practice Procedures With Its Single-Port Robotic Surgical System
    7/18/2019

    Titan Medical Inc., a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that all procedures under Good Laboratory Practice (“GLP”) principles associated with the acute and chronic animal studies and human cadaver studies using its single-port robotic surgery system have been completed

  8. Sysmex America To Exhibit New Products, Automation & Quality Solutions For Optimized Clinical Laboratory Performance At AACC 2019
    7/18/2019

    Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis and flow cytometry testing technology that improves clinical laboratory performance, will be exhibiting at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California, August 6 – 8, at booth #1063

  9. Know Labs Announces Significant Pre-Clinical Progress Of UBAND Non-Invasive Continuous Glucose Monitor
    7/17/2019

    Know Labs, Inc. – a creator of innovative medical diagnostic solutions, recently announced significant progress in the development of its wearable UBAND non-invasive Continuous Glucose Monitor (CGM)

  10. Menarini Silicon Biosystems Launches VRNxT Volume Reduction Instrument
    7/17/2019

    Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced that it will launch the new VRNxT™, a volume reduction instrument optimized to remove manual sample volume reduction steps in cellular biology workflows